Inhibrx Biosciences, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Inhibrx Biosciences, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2023 to Q2 2025.
  • Inhibrx Biosciences, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2025 was $2.17M, a 0.09% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $2.17M -$2K -0.09% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $1.97M Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $1.6M -$468K -22.7% Dec 31, 2024 10-Q 2025-08-13
Q3 2024 $1.84M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.17M Jun 30, 2024 10-Q 2024-08-13
Q4 2023 $2.06M Dec 31, 2023 10-K 2025-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.